Monica Bhatia, MD

Specialties:
Cancer Care, Pediatric Hematology-Oncology, Pediatrics

More specialties
Accepting New Patients

Treats Children

Profile Navigation

Overview
Schedule an Appointment
Location(s)
Insurance Accepted
Credentials & Experience
Research
Related News

Overview

Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients.
The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives.
NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease.
Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease.
Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.

Areas of Expertise / Conditions Treated

Acute Myeloid Leukemia
Bone Marrow Disorders
Bone Marrow Stem Cell Transplants
Chemotherapy
Hemoglobinopathy
Immunodeficiency Disorder
Pediatric Bone Marrow
Sickle Cell Anemia

Academic Appointments

Associate Professor of Pediatrics at CUMC

Administrative Titles

Director, Pediatric Stem Cell Transplant Program

Hospital Affiliations

NewYork-Presbyterian / Columbia University Irving Medical Center
NewYork-Presbyterian Morgan Stanley Children's Hospital

Gender

Female

Schedule an Appointment

Phone Appointments

New and Existing Patients: (212) 305-9770

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Location(s)

CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
CHN 10-07
New York, NY 10032

Primary

Phone: (212) 305-9770


Fax: (212) 305-8408



Open location in Google Maps



CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue

New York, NY 10032



Phone: (212) 305-9770


Fax: (212) 305-8408



Open location in Google Maps

Insurance Accepted

Aetna

Aetna Signature Administrators
EPO
HMO
Medicare Managed Care
NYP Employee Plan
NY Signature
POS
PPO
Student Health

Affinity Health Plan

Essential Plan
Medicaid Managed Care

Amida Care

Special Needs

Cigna

EPO
Great West (National)
HMO
POS
PPO

Emblem/GHI

Medicare Managed Care
PPO

Emblem/HIP

ConnectiCare
EPO
Essential Plan
HMO
Medicaid Managed Care
Medicare Managed Care
POS
PPO
Select Care (Exchange)
Vytra

Empire Blue Cross/Blue Shield

EPO
HMO
Medicare Managed Care
PPO

Empire Blue Cross Blue Shield HealthPlus

Child/Family Health Plus
Essential Plan
Medicaid Managed Care

Fidelis Care

Child/Family Health Plus
Essential Plan
Medicaid Managed Care
Medicare Managed Care

Healthfirst

Child/Family Health Plus
Leaf (Exchange)
Medicaid Managed Care
Medicare Managed Care

Local 1199

Local 1199

MagnaCare (National)

MagnaCare

Medicare

Railroad
Traditional Medicare

Multiplan

Multiplan

MVP Health Care

Child/Family Health Plus
Essential Plan
HMO
Medicaid Managed Care

Oxford Health Plans

Freedom
Liberty

UnitedHealthcare

Compass (Exchange)
Empire Plan
HMO
Medicaid (Community Plan)
Medicare Managed Care
POS
PPO

VNSNY CHOICE

Medicare Managed Care
SelectHealth
Special Needs

WellCare

Medicaid Managed Care
Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

St. George's University School of Medicine (Grenada)
Residency: Albany Medical Center Hospital, NY
Fellowship: Childrens National Medical Center

Board Certifications

Pediatrics
Pediatric Hematology-Oncology



NY Top Doctor

Research

Clinical Trials

NCT00408447 Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients With Sickle Cell Disease and Thalassemia
NCT00920972 A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime
NCT02452034 A Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous (IV) and Powder for Oral Suspension Formulations of Posaconazole (POS) in Immunocompromised Pediatric Subjects With Neutropenia
NCT02766465 A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults With Severe Sickle Cell Disease (BMT CTN #1503)
NCT02851407 A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
NCT02867800 Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial


For a complete list of publications, please visit PubMed.gov

Related News

Clinical Trial Begins for Promising Sickle Cell Gene Editing Treatment

October 5, 2020

Topic

Pediatrics